CUTANEOUS squamous cell carcinoma imaging steering might standardize staging and surveillance for greater threat localized illness.
Cutaneous Squamous Cell Carcinoma Imaging Steering
A multidisciplinary Delphi consensus has produced knowledgeable suggestions for staging and surveillance imaging in localized cutaneous squamous cell carcinoma, addressing a protracted standing hole in medical steering. The examine was developed in response to the absence of consensus on when imaging ought to be utilized in cutaneous squamous cell carcinoma, regardless of proof that imaging can have an effect on administration and broad suggestions which have contributed to variability in follow.
The knowledgeable panel included 45 individuals who accomplished three iterative survey rounds between January and June 2025. Specialists represented dermatology, medical oncology, radiation oncology, radiology, surgical procedure, and otolaryngology, reflecting the multidisciplinary nature of cutaneous squamous cell carcinoma care. Consensus was outlined as a minimum of 80% settlement, whereas close to consensus was outlined as 70% to 79% settlement.
Increased Threat Options Drive Imaging Suggestions
The panel beneficial staging and surveillance imaging for cutaneous squamous cell carcinomas with a minimum of a 15% threat of metastasis. Consensus or close to consensus supported imaging when tumors raised concern for metastasis, bone invasion, invasion past subcutaneous fats, giant caliber nerve invasion, or a diameter of 4 cm or bigger.
Imaging was additionally beneficial for tumors with poorly differentiated histology when accompanied by extra threat options. These included a diameter of two cm or bigger, lymphovascular invasion with subcutaneous fats invasion, or lymphovascular invasion with small caliber perineural invasion. Collectively, these suggestions present a extra structured strategy to figuring out sufferers whose illness could warrant radiologic evaluation.
CT Most well-liked For Staging And Surveillance
Computed tomography imaging emerged as the popular modality for nodal staging, supported by 38 panelists, representing 84% settlement. It was additionally the popular modality for surveillance, supported by 35 panelists, representing 78% settlement.
For surveillance period, the panel reached consensus on imaging for a minimum of 2 years, with close to consensus supporting imaging for a minimum of 3 years. The authors concluded that this knowledgeable consensus based mostly framework could assist standardize imaging use in localized cutaneous squamous cell carcinoma and inform future tips.
Reference
Kassamali B et al. Consensus Tips for Staging and Surveillance Imaging in Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2026;doi:10.1001/jamadermatol.2026.2163.
Featured Picture: fizkes on Adobe Inventory.








